alprazolam XR

DRUG4 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions

Panic DisorderPharmacokinetics

Phase 1

Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population

CompletedNCT00810316

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Pharmacokinetics

Start: 2008-10-31End: 2008-11-30Updated: 2021-01-28

Phase 4

A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks

TerminatedNCT00634790

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Panic Disorder

Start: 2004-05-31End: 2004-10-31Updated: 2021-01-28

A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder

TerminatedNCT00635076

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Panic Disorder

Start: 2004-07-31End: 2004-09-30Updated: 2021-01-28

A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

TerminatedNCT00635531

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Panic Disorder

Start: 2004-04-30End: 2004-09-30Updated: 2021-01-28